series-a
Stage
1
Investors
About
Auransa is a clinical stage, AI-native biopharma with a proprietary AI platform that harnesses available human disease data to discover novel therapeutics and raise the standard of care for cancer.
Explore Auransa's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.